Antoun C, Oto J, Morelli V, Hveem K, Braekkan S, Medina P
Int J Mol Sci. 2025; 26(5).
PMID: 40076809
PMC: 11899732.
DOI: 10.3390/ijms26052191.
Aune D, Nordsletten M, Myklebust T, Robsahm T, Skalhegg B, Mala T
BMC Cancer. 2025; 25(1):243.
PMID: 39934750
PMC: 11817836.
DOI: 10.1186/s12885-025-13637-8.
Saeter M, Johansen S, Reinertsen K, Thorsen L, Haugaa K, Nilsen T
Cardiooncology. 2025; 11(1):1.
PMID: 39755716
PMC: 11699684.
DOI: 10.1186/s40959-024-00296-0.
Oakley L, Kristjansson D, Munthe-Kaas M, Nguyen H, Lee Y, Hanevik H
Hum Reprod. 2024; 40(2):382-390.
PMID: 39724532
PMC: 11788205.
DOI: 10.1093/humrep/deae285.
Gheorghiu A, Brunborg C, Johannesen T, Helseth E, Zwart J, Wiedmann M
Front Oncol. 2024; 14:1471733.
PMID: 39703841
PMC: 11656313.
DOI: 10.3389/fonc.2024.1471733.
Socioeconomic and geographic variation in adjuvant chemotherapy among elderly patients with stage III colon cancer in Norway - a national register-based cohort study.
Gustavsen E, Norderval S, Dorum L, Balto A, Heimdal R, Vonen B
Res Health Serv Reg. 2024; 3(1):21.
PMID: 39688645
PMC: 11652436.
DOI: 10.1007/s43999-024-00057-7.
Occupational exposures of firefighting and prostate cancer risk in the Norwegian Fire Departments Cohort.
Marjerrison N, Grimsrud T, Hansen J, Martinsen J, Nordby K, Olsen R
Scand J Work Environ Health. 2024; 51(2):100-110.
PMID: 39673513
PMC: 11895083.
DOI: 10.5271/sjweh.4202.
Body mass index and penile cancer incidence: results from a Norwegian cohort study of 829,081 men.
Aune D, Nordsletten M, Myklebust T, Robsahm T, Skalhegg B, Mala T
BMC Urol. 2024; 24(1):260.
PMID: 39605013
PMC: 11603744.
DOI: 10.1186/s12894-024-01636-z.
Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study.
Busund M, Ursin G, Lund E, Chen S, Rylander C
Breast Cancer Res. 2024; 26(1):151.
PMID: 39497219
PMC: 11536865.
DOI: 10.1186/s13058-024-01897-4.
The association between body mass index and vulvar and vaginal cancer incidence: findings from a large Norwegian cohort study.
Aune D, Nordsletten M, Myklebust T, Robsahm T, Skalhegg B, Mala T
Cancer Causes Control. 2024; 36(2):191-198.
PMID: 39463212
PMC: 11774981.
DOI: 10.1007/s10552-024-01930-z.
Factors behind favorable long-term lung cancer survival in Norway compared to Denmark: a retrospective cohort study.
Gouliaev A, Berg J, Khalil A, Dalton S, Rasmussen T, Christensen N
Eur Clin Respir J. 2024; 11(1):2414485.
PMID: 39391702
PMC: 11465383.
DOI: 10.1080/20018525.2024.2414485.
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection.
Gjesvik J, Moshina N, Lee C, Miglioretti D, Hofvind S
JAMA Netw Open. 2024; 7(10):e2437402.
PMID: 39361281
PMC: 11450515.
DOI: 10.1001/jamanetworkopen.2024.37402.
Lifestyle and metabolic factors affect risk for meningioma in women: a prospective population-based study (The Cohort of Norway).
Gheorghiu A, Brunborg C, Johannesen T, Helseth E, Zwart J, Wiedmann M
Front Oncol. 2024; 14:1428142.
PMID: 39188673
PMC: 11345274.
DOI: 10.3389/fonc.2024.1428142.
Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries.
Nikkila R, Haapaniemi A, Carpen T, Pukkala E, Makitie A
Acta Oncol. 2024; 63:612-619.
PMID: 39099322
PMC: 11332480.
DOI: 10.2340/1651-226X.2024.40823.
Data quality in Brazilian population-based cancer registries for gastrointestinal cancers.
Mendonca E Silva D, Oliveira M, Curado M
BMC Cancer. 2024; 24(1):870.
PMID: 39030476
PMC: 11264711.
DOI: 10.1186/s12885-024-12477-2.
Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches.
Stawiski K, Fortner R, Pestarino L, Umu S, Kaaks R, Rounge T
Front Oncol. 2024; 14:1389066.
PMID: 38983926
PMC: 11231195.
DOI: 10.3389/fonc.2024.1389066.
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.
Stoer N, Vangen S, Singh D, Fortner R, Hofvind S, Ursin G
Br J Cancer. 2024; 131(1):126-137.
PMID: 38740969
PMC: 11231299.
DOI: 10.1038/s41416-024-02590-1.
Quadrivalent HPV Vaccine Effectiveness Against Cervical Intraepithelial Lesion Grade 2 or Worse in Norway: A Registry-Based Study of 0.9 Million Norwegian Women.
Orumaa M, Lahlum E, Gulla M, Tota J, Nygard M, Nygard S
J Infect Dis. 2024; 230(6):e1202-e1206.
PMID: 38658353
PMC: 11646582.
DOI: 10.1093/infdis/jiae209.
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma.
Kragh Jorgensen R, Bergstrom F, Eloranta S, Severinsen M, Bjoro Smeland K, Fossa A
JCO Clin Cancer Inform. 2024; 8:e2300255.
PMID: 38608215
PMC: 11161240.
DOI: 10.1200/CCI.23.00255.
Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway.
Larsen M, Olstad C, Lee C, Hovda T, Hoff S, Martiniussen M
Radiol Artif Intell. 2024; 6(3):e230375.
PMID: 38597784
PMC: 11140504.
DOI: 10.1148/ryai.230375.